Search
Search Results
##search.searchResults.foundPlural##
-
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
1037PDF: 1274HTML: 127 -
The diagnostic pitfalls of mucormycosis
1013PDF: 746HTML: 290 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1347PDF: 1001HTML: 97 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1808PDF: 1233HTML: 337 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1779PDF: 772HTML: 2351 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
4052PDF: 779HTML: 1887 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277817PDF: 1849HTML: 3898 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1352PDF: 1118HTML: 249 -
THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis
1501PDF: 1470PDF: 1045HTML: 231 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2471PDF: 1471HTML: 2021 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1658PDF: 1104HTML: 478 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2290PDF: 2115HTML: 217 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1894PDF: 943HTML: 1018Referring article: 777 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
953PDF: 726HTML: 361 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1469PDF: 853HTML: 8673Fig 3 Savini: 201Fig 2 Savini: 206Fig 1 Savini Chest TC: 205Author letter to referees: 212 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
207PDF: 198HTML: 16 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1152PDF: 1270HTML: 119 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2336PDF: 919HTML: 2014Fig 1 Rossi: 220 -
SPHINGOMONAS PAUCIMOBILIS INFECTIONS IN CHILDREN: NOSOCOMIAL VERSUS COMMUNITY ACQUIRED INFECTIONS
1859PDF: 1053HTML: 2079cover: 201Table 1. Co-morbidities associated with Sphingomonas paucimobilis infections.: 205Figure 1. The antimicrobial susceptibility patterns of Sphingomonas paucimobilis isolated from clinical specimens: 1726title page: 206







